申请人:HECKEL Armin
公开号:US20130143892A1
公开(公告)日:2013-06-06
The present invention relates to compounds of general formula I,
wherein R
1
, L
P
, HetAr, Ar, and n are as defined in the application, which have valuable pharmacological properties, and in particular bind to the GPR119 receptor and modulate its activity.
本发明涉及一般式I的化合物,其中R1,LP,HetAr,Ar和n如本申请中所定义,具有有价值的药理学性质,特别是与GPR119受体结合并调节其活性。